Back to search

Effects of dose, sex, and long-term abstention from use on toxic effects of MDMA (ecstasy) on brain serotonin neurons

Data up to Jan 2025

Published2001
Citations253
References28
Clinical Trials (1)

Total Citations Per Year

Abstract

References (28)

Association of Anxiety-Related Traits with a Polymorphism in the Serotonin Transporter Gene Regulatory Region

1996 • 5,154 citations

A prospective study of estrogen replacement therapy and the risk of developing Alzheimer's disease

1997 • 965 citations

Positron emission tomographic evidence of toxic effect of MDMA (“Ecstasy”) on brain serotonin neurons in human beings

1998 • 673 citations

Neurotoxicity of the psychedelic amphetamine, methylenedioxymethamphetamine.

1987 • 526 citations

A Sexually Dimorphic Nucleus in the Human Brain

1985 • 515 citations

Reduced brain serotonin transporter availability in major depression as measured by [123I]-2β-carbomethoxy-3β-(4-iodophenyl)tropane and single photon emission computed tomography

1998 • 507 citations

Biochemical and histological evidence that methylenedioxymethylamphetamine (MDMA) is toxic to neurons in the rat brain.

1987 • 451 citations

Evidence for a Gender-Related Effect of Alcoholism on Brain Volumes

2001 • 348 citations

Altered Serotonin Innervation Patterns in the Forebrain of Monkeys Treated with (±)3,4-Methylenedioxymethamphetamine Seven Years Previously: Factors Influencing Abnormal Recovery

1999 • 340 citations

Gender differences in the subjective effects of MDMA

2001 • 340 citations

Serotonin Neurotoxicity after (±)3,4-Methylenedioxymethamphetamine (MDMA; “Ecstasy”): A Controlled Study in Humans

1994 • 336 citations

(±3,4-Methylenedioxymethamphetamine Selectively Damages Central Serotonergic Neurons in Nonhuman Primates

1988 • 294 citations

Reduced in vivo binding to the serotonin transporter in the cerebral cortex of MDMA (‘ecstasy’) users

1999 • 286 citations

Graphical, Kinetic, and Equilibrium Analyses of in vivo [123I]β-CIT Binding to Dopamine Transporters in Healthy Human Subjects

1994 • 274 citations

Lasting effects of (+-)-3,4-methylenedioxymethamphetamine (MDMA) on central serotonergic neurons in nonhuman primates: neurochemical observations.

1992 • 262 citations

Pet study of [11C] β‐CIT binding to monoamine transporters in the monkey and human brain

1994 • 184 citations

3,4-Methylenedioxy analogues of amphetamine: Defining the risks to humans

1999 • 182 citations

Imaging serotonin and dopamine transporters with 123I-beta-CIT SPECT: binding kinetics and effects of normal aging.

2000 • 181 citations

Imaging of the dopaminergic neurotransmission system using single-photon emission tomography and positron emission tomography in patients with parkinsonism

1999 • 175 citations

3,4-Methylenedioxymethamphetamine ("ecstasy") selectively destroys brain serotonin terminals in rhesus monkeys.

1989 • 162 citations

In vivo detection of short- and long-term MDMA neurotoxicity?a positron emission tomography study in the living baboon brain

1998 • 143 citations

Long-lasting effects of (±)3,4-methylene-dioxymethamphetamine (Ecstasy) on serotonin system function in humans

2000 • 143 citations

?-CIT SPECT demonstrates blockade of 5HT-uptake sites by citalopram in the human brain in vivo

1995 • 131 citations

Gender Effects on Persistent Cerebral Metabolite Changes in the Frontal Lobes of Abstinent Cocaine Users

1999 • 120 citations

Methylenedioxymethamphetamine-induced serotonin deficits are followed by partial recovery over a 52-week period. Part I: Synaptosomal uptake and tissue concentrations.

1996 • 109 citations

MDMA (Ecstasy) neurotoxicity: assessing and communicating the risks

2000 • 101 citations

Methylenedioxymethamphetamine-induced serotonin deficits are followed by partial recovery over a 52-week period. Part II: Radioligand binding and autoradiography studies.

1996 • 94 citations

MDMA (“ecstasy”) abuse: Psychopathological features and craving for chocolate: A case series

1994 • 63 citations

Cited By (0)

Loading...